Are nuclear factors the ultimate targets of drugs affecting lipid metabolism?
Fruchart
J C
JC
Département d'Athérosclérose, INSERM U325, Institut Pasteur et Université de Lille 2, 1 rue du Professeur Calmette, BP 245, 59019, Lille, France. Jean-Charles.Fruchart@pasteur-lille.fr
D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D050356:Lipid Metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000378:metabolism*
D018160:Receptors, Cytoplasmic and Nuclear